Talk:Abderhalden–Kaufmann–Lignac syndrome

WikiProject class rating

This article was automatically assessed because at least one WikiProject had rated the article as stub, and the rating on other projects was brought up to Stub class. BetacommandBot 16:23, 10 November 2007 (UTC)

Merge into cystinosis

This article should be merged into cystinosis. "Abderhalden-Kaufmann-Lignac" is a deprecated eponym for cystinosis. PubMed has a single mention of Abderhalden-Kaufmann-Lignac syndrome, a 1987 case report written in Russian (PMID: 3606421). "Abderhalden-Kaufmann-Lignac" is not found in OMIM. The archived NIH page linked to (https://web.archive.org/web/20180515112643/https://rarediseases.info.nih.gov/diseases/10074/abderhalden-kaufmann-lignac-syndrome) in the article just has a title, but not informational content. Jaredroach (talk) 16:28, 28 February 2024 (UTC)

Support: This article[1] states "Emil Abderhalden (1877-1950), a Swiss scientist, described cystinosis as familial cystine accumulation disease in 1903. Eduard Kaufmann (1860-1931) first met a child named Abderhalden in Basel, Switzerland. During the postmortem investigation, it was found that the patient had substantial cystine accumulation in several organs at the age of 21 months. The disease was first clearly and systematically described in 1924 by the Dutch pathologist George Lignac (1891–1954), who was also the first to link cystinosis to its main clinical signs, including growth retardation, renal failure, and rickets. For this reason, the original name for cystinosis was Abderhalden-Kaufmann-Lignac syndrome." implying that Abderhalden-Kaufmann-Lignac syndrome is a historical term. CursedWithTheAbilityToDoTheMath (talk) 04:14, 29 February 2024 (UTC)

OK. I think this is an obvious Type 1 merge that does not need further discussion. WP:MERGE Jaredroach (talk) 20:39, 1 March 2024 (UTC)